Adeno-associated virus-vectored gene therapy for retinal disease.
about
Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosisRecovery of neuronal and network excitability after spinal cord injury and implications for spasticityPromising and delivering gene therapies for vision lossLentiviral expression of retinal guanylate cyclase-1 (RetGC1) restores vision in an avian model of childhood blindnessComparative analysis of DNA nanoparticles and AAVs for ocular gene deliveryRetinal degeneration progression changes lentiviral vector cell targeting in the retinaGene therapy regenerates protein expression in cone photoreceptors in Rpe65(R91W/R91W) mice.Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potentialROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS.Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse.DNA delivery in adult mouse eyes: an update with corneal outcomes.Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.In vivo gene delivery in the retina using polyethylenimineEvaluation of AAV-mediated expression of Chop2-GFP in the marmoset retinaTransduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injectionReduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.Vector platforms for gene therapy of inherited retinopathies.X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors.Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.In vitro analysis of promoter activity in Müller cellsAAV-mediated gene transfer for retinal diseases.Combined therapies in the treatment of neurotrauma: polymers, bridges and gene therapy in visual system repair.The genomic response of the retinal pigment epithelium to light damage and retinal detachment.Technical brief: subretinal injection and electroporation into adult mouse eyes.Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes.Inherited diseases of photoreceptors and prospects for gene therapy.Gene therapy: regulations, ethics and its practicalities in liver disease.AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical modelsTargeting gene expression to cones with human cone opsin promoters in recombinant AAV.The role of the photoreceptor ABC transporter ABCA4 in lipid transport and Stargardt macular degeneration.Gene therapy approaches for the treatment of retinal disordersInsights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.Adeno-associated virus (AAV) based gene therapy for eye diseases.Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Gene therapy in animal models of autosomal dominant retinitis pigmentosaGene therapy for retinal diseaseAdeno-associated virus type 8 vector-mediated expression of siRNA targeting vascular endothelial growth factor efficiently inhibits neovascularization in a murine choroidal neovascularization modelCharacterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site
P2860
Q21144697-E604A5AF-C143-4C5D-9501-8FF997929410Q26825721-C4239576-1D54-4044-8557-D6A4A86CC18FQ27007079-ACE0214B-4983-4A83-BBA1-F3A916654BB3Q27307727-1577967E-9310-4DC5-A0C5-EFB74C379263Q27325842-788CCFC1-B76E-4720-BA4C-AFC4C9FCEB7BQ28741007-E2E727A0-10D7-4ED7-AA19-61F97473102DQ30999247-EA995705-6CCD-4567-902B-2C9179D83692Q33267297-C712DBDC-6D60-44ED-B326-45043C0197EEQ33374015-A5125A0B-7542-40F5-92FC-868A49A14586Q33720369-C10C81A6-C9E7-477F-92C3-730010DF5007Q33787600-858D2D33-7895-4094-8A73-FFE84DD486F8Q33852810-87C7A74A-5EFC-4E3A-8A0B-4E743812810BQ33886878-1FD28A4F-C2F9-426B-8482-31D19632817AQ33914306-FC616EC6-4743-43D5-898E-D2B2D80129F9Q34126575-43BC580D-0F17-460E-B91C-E5BDE38C8F2BQ34233343-F6CD0841-E6E9-466C-8DA7-E0B0CAB85A2BQ34451693-EDCFE12A-AA13-424D-A7C0-2AD34B9F3228Q34561531-FD5BDBA3-1635-4344-843D-0B02B9CF9372Q35907087-D0BBF30D-8860-46A3-86AE-67C243C214D1Q36099346-0E3EDAF4-B1C2-4CFE-9718-66C63888398FQ36545533-90F5E8F4-8F05-4B40-8A8D-83E7F3B9E071Q36580252-D0A8B2C3-EC26-48C2-ACB6-76A47509EDD4Q36708300-F5116149-9FD9-4716-B493-970E323BDDC1Q36878911-D01D5CC3-95D8-4834-90BA-EC63F7BC94C4Q36944774-20B92322-A254-4FC8-927A-789A2B7DC582Q36995732-0FE162A0-F641-4075-BE60-2D47E961602FQ37043579-040D135B-B535-4E08-A925-B63BF51000E9Q37096060-75411B6A-9BD7-4671-BFBB-AB19B915AED0Q37139713-73883B61-6390-4D21-9A54-2E4247E93BEBQ37301637-5734650F-BCF0-4320-A56F-5CF8A44F4F31Q37304864-459D3423-CF49-4ABB-8F42-CAB7E7D6DC7EQ37351985-81DFF270-F0F6-4FBC-AC80-6834A8383C17Q37481357-3ADB02E4-E238-452C-B121-360CFFFA0334Q37636830-7DD5AFFA-052C-41C2-A4D9-907EEC95F810Q37846117-9387B427-C282-43D6-9288-964DC1EB5B2BQ37945218-9D2F71CB-2F16-4A0A-9713-94F72D1097A3Q38053151-ECE5A2FE-8CF1-45DE-A308-7962003DB9F5Q38073020-DC190899-324A-4357-AC14-C8D78F7198F1Q38714555-D843CBFA-06E9-424D-9E3E-E678745FD306Q38787435-9B2B6148-044F-4F87-AC67-FEABCC7703E9
P2860
Adeno-associated virus-vectored gene therapy for retinal disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Adeno-associated virus-vectored gene therapy for retinal disease.
@ast
Adeno-associated virus-vectored gene therapy for retinal disease.
@en
Adeno-associated virus-vectored gene therapy for retinal disease.
@nl
type
label
Adeno-associated virus-vectored gene therapy for retinal disease.
@ast
Adeno-associated virus-vectored gene therapy for retinal disease.
@en
Adeno-associated virus-vectored gene therapy for retinal disease.
@nl
prefLabel
Adeno-associated virus-vectored gene therapy for retinal disease.
@ast
Adeno-associated virus-vectored gene therapy for retinal disease.
@en
Adeno-associated virus-vectored gene therapy for retinal disease.
@nl
P2093
P356
P1433
P1476
Adeno-associated virus-vectored gene therapy for retinal disease.
@en
P2093
Astra Dinculescu
Lyudmyla Glushakova
Seok-Hong Min
William W Hauswirth
P304
P356
10.1089/HUM.2005.16.649
P577
2005-06-01T00:00:00Z